<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02921750</url>
  </required_header>
  <id_info>
    <org_study_id>CHEXU03</org_study_id>
    <nct_id>NCT02921750</nct_id>
  </id_info>
  <brief_title>Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin</brief_title>
  <acronym>PD-497314</acronym>
  <official_title>A Randomised Multi-centre Non-inferiority Investigation to Evaluate the Efficacy and Safety of Exufiber Versus Aquacel Extra in Moderately or Strongly Exuding Venous and Mixed Ulcers of Predominantly Venous Origin</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Molnlycke Health Care AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Molnlycke Health Care AB</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigation is designed as an open, randomized, non-inferiority, multi-centre
      investigation.

      212 evaluable subjects will be randomised. Subjects to be included will suffer from an
      exuding venous or mixed ulcer of predominantly venous origin. Subjects will either be
      randomized to Exufiber® or Aquacel® Extra using centralized randomization
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Visits are planned for baseline followed by 1, 2, 3, 4 and 6 weeks post treatment. The
      sub-group of at least 50 subjects will also be followed at week 8, 12, 16, 20, and 24 post
      treatment or until wound is healed if earlier.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Reduction (%)</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relative reduction of sloughy tissue, measured with photo analysis</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound area reduction (cm2)</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Linear advance of the wound margin according to Gilman's formula</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Debrided wound (%)</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of additional debridements</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain during debridement measured by VAS</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in the condition of peri-wound skin measured by investigator judgement</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain in connection of removal of the dressing, measured by VAS by the patient</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in wound status including exudate management, measured by investigator judgement</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician's and subject's opinion related to the dressing. Both opinion measured by questionnaires</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>6 - 24 weeks</time_frame>
    <description>EQ5D-3L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events/Adverse device effects</measure>
    <time_frame>6 - 24 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of debridement measured by investigator judgement</measure>
    <time_frame>6 weeks</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Wound healing</measure>
    <time_frame>24 weeks</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">212</enrollment>
  <condition>Venous Leg Ulcer</condition>
  <arm_group>
    <arm_group_label>Dressing Exufiber</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>will receive dressing Exufiber</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dressing Aquacel Extra</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Will receive Aquacel Extra</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Exufiber</intervention_name>
    <description>Gelling fibre dressing</description>
    <arm_group_label>Dressing Exufiber</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Aquacel Extra</intervention_name>
    <description>Gelling fibre dressing</description>
    <arm_group_label>Dressing Aquacel Extra</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provision of informed consent i.e. subject must be able to understand and sign the
             Patient Information and Consent Form

          2. Both gender ≥18 years old

          3. Ulcer moderately or strongly exudative justifying the use of an absorbent dressing

          4. (History of compression at least two weeks before inclusion) Deleted in Am.2

          5. (Wound covered with slough ≥70%) Deleted in Am.4

          6. 0.7≤ABPI&lt;1.3

          7. Ulcer duration 6 weeks to 60 months

          8. Ulcer size 3 cm2-100 cm2

          9. Target ulcer at least 3 cm away from any other lesion

        Exclusion Criteria:

          1. Known allergy/hypersensitivity to the dressings

          2. Pregnant or breastfeeding

          3. Circumferential wounds (the entire wound should be able to be captured on a single
             image/photo)

          4. Subjects who will have problems following the protocol

          5. Subjects included in other ongoing clinical investigation evaluating wound dressings
             at present or during the past 30 days

          6. Patient with a systemic infection not controlled by suitable antibiotic treatment

          7. Clinically infected wound according to the judgement of the investigator (heat, pain,
             swelling, redness or purulent secretion)

          8. Wound covered with black necrosis

          9. Dry wounds

         10. Malignant wound degeneration

         11. Current treatment with radiotherapy, chemotherapy, immunosuppressant drugs or high
             doses of oral corticosteroids if any

         12. Subject with deep vein thrombosis within 3 months prior to inclusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bo Joergensen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bispebjerg Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ann-Sofie Svensson, Ph.D</last_name>
    <email>ann-sofie.svensson@molnlycke.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Copenhagen NV</state>
        <zip>2200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Department of Vascular Surgery</name>
      <address>
        <city>Viborg</city>
        <zip>8800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Services Rhumatologie et Dermatologie</name>
      <address>
        <city>Chambray Les Tours</city>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Michallon</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier</name>
      <address>
        <city>La Rochelle</city>
        <zip>17019</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Géneral du Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Wundzentrum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>86152</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>WundZentrum Dortmund</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>WundZentrum Düsseldorf</name>
      <address>
        <city>Düsseldorf</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Venenzentrum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>79008</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Paracelsus-Klinik am Silbersee</name>
      <address>
        <city>Hannover</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein</name>
      <address>
        <city>Kiel</city>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Johannes-Gutenberg-Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>WundZentrum München Nord</name>
      <address>
        <city>München</city>
        <zip>80939</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>WundZentrum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>89077</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lund university Hospital,</name>
      <address>
        <city>Lund</city>
        <zip>22185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Skellefteå Lasarett</name>
      <address>
        <city>Skellefteå</city>
        <zip>931 41</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset (Sårcentrum)</name>
      <address>
        <city>Stockholm</city>
        <zip>118 83</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset (Hudkliniken)</name>
      <address>
        <city>Stockholm</city>
        <zip>11883</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Avdelningen för kliniska prövningar, Universitetssjukhuset Örebro</name>
      <address>
        <city>Örebro</city>
        <zip>70185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Sweden</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2016</study_first_submitted>
  <study_first_submitted_qc>September 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2016</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>wound reduction wound healing, venous ulcers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Varicose Ulcer</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carboxymethylcellulose Sodium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

